{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:57:47Z","timestamp":1769281067826,"version":"3.49.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajem.2023.01.030","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:20:03Z","timestamp":1674850803000},"page":"172-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Administration of 3% hypertonic saline via peripheral route: Is it really safe?"],"prefix":"10.1016","volume":"66","author":[{"given":"Teenu","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afzal","family":"Azim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2023.01.030_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fmed.2019.00047","article-title":"Misconceptions and barriers to the use of hypertonic saline to treat hyponatraemic encephalopathy","volume":"6","author":"Ayus","year":"2019","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajem.2023.01.030_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0885066617702590","article-title":"Incidenceofadverse events during peripheral administration of sodium chloride 3","volume":"33","author":"Dillon","year":"2018","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.ajem.2023.01.030_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajem.2022.10.051","article-title":"Safety of peripherally administered 3% hypertonic saline","volume":"63","author":"Deveau","year":"2023","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2023.01.030_bb0020","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet].Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012\u20132019. Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury."},{"key":"10.1016\/j.ajem.2023.01.030_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0148607114521833","article-title":"A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labelling, and dispensing","volume":"38","author":"Boullata","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2023.01.030_bb0030","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajem.2023.01.030_bb0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the acute treatment of cerebral edema in neurocritical care patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ajem.2023.01.030_bb0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/ALN.0b013e31823c9569","article-title":"Practice guidelines for central venous access: a report by the American Society of Anesthesiologists Task Force on central venous access","volume":"116","author":"Rupp","year":"2012","journal-title":"Anesthesiology."}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T21:11:08Z","timestamp":1760562668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":8,"alternative-id":["S0735675723000347"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.01.030","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Administration of 3% hypertonic saline via peripheral route: Is it really safe?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}